Think Asian Growth. Think Deallus Consulting

We would like to take a moment to give you a brief introduction to Deallus’ capabilities in providing Asian Market Insights to support Asian Market Entry Strategies.

Leveraging our extensive experience in understanding the healthcare landscape within the region and outstanding research capabilities, Deallus is able to obtain deep market insights across all key pharmaceutical stakeholders.

Deallus utilises market specific insights and real-world data and expertise to develop relevant, realistic and actionable recommendations that will help inform key business decisions concerning the entry strategy for emerging markets.

We help you build confidence in strategies and tactics pertaining to product registration, launch and commercialisation, by detailed evaluation of your competitor, pricing and market access and regulatory landscapes in a very diverse and complex group of markets.

In just the last 6 months, our projects have served customers seeking to understand the following markets: Singapore, Thailand, Philippines, Indonesia, South Korea, India, Taiwan, Hong Kong, Malaysia, Vietnam and Australia.

Why work with us?

  • Legacy: from our office in Singapore, we have completed over >60 projects with an Asia focus over the past 4 years, supporting multiple top 30 pharma decision makers throughout the product and portfolio lifecycle
  • Expertise: our market specific insights are complemented by our specialist industry understanding, local knowledge and a team of consultants with local language capabilities
  • Evidence Based: complemented by our industry leading research capabilities, our deliverables aim to ensure that all recommendations are based on the most up-to-date insights from the market and the competitive landscape, maximising your confidence to action your downstream strategy
  • Seamless Execution: we understand that developing a market entry strategy for a new region can be a high profile undertaking in any organisation; every project engagement consists of seamless scoping, management and delivery to ensure a smooth and professionally outcome
  • Results Focused: our average client retention rate is >95%. Repeat projects are regularly requested by clients, often taking learnings from a global or regional level to the affiliate level

Get Inspired – A selection of projects we have completed in the last 6 months

  • Developed competitive insights on a regional level and facilitated a successful launch workshop with the regional and affiliate teams with a focus on India, Australia, Singapore, Philippines and Thailand (Diabetes, APAC Scope)
  • Developed market size projections in support of value proposition and arguments to use with payers and governments in Indonesia, Philippines, Taiwan, Hong Kong, Thailand, Malaysia, Vietnam, Japan (Pediatric, APAC scope)
  • Commercial mapping of key competitors to help client develop a sustainable market position in antipsychotics in Thailand and Taiwan (CNS, APAC Scope)
  • Delivered a approvability assessment for a product marketed already in Japan to determine the best regulatory strategy to enable a launch in Thailand, Singapore, Malaysia, Philippines, Vietnam, and Indonesia (CNS, ASEAN)
  • Conducted a competitive strategy assessment into the long term portfolio development for a top 10 Japanese Pharma client, delivering strategic recommendations to invest and grow in 2 out of 6 therapy areas while deprioritizing others (LCM, Japan)

Our clients say…

“The Deallus Singapore team did a good job. The project was well researched and conducted; they found ingenious ways to seek answers to the overarching questions. They met the timelines. It was nice working with them.” Senior Business Analyst, Top 20 Pharma Co.

“The Deallus team provided great regulatory input even going beyond project scope.  Many thanks for your great research. The reports are able to support our business decisions.” Manager Business Planning, Top 20 Japanese Pharma Co.

“We appreciated your kind cooperation and efforts to hear from KOLs in Thailand and Taiwan in the limited time available. The report is helpful to consider our marketing strategy in these countries.” Senior Manager, Global Strategy, Top 20 Japanese Pharma Co.

“Deallus really worked hard to find evidence to help us make a stronger case for each country.” Commercial Operations, Top 20 Pharma Co.